share_log

Crude Oil Rises; Blend Labs Shares Jump Following Q2 Results

Crude Oil Rises; Blend Labs Shares Jump Following Q2 Results

wti原油上漲;Blend Labs股票在Q2業績公佈後大幅上漲。
Benzinga ·  08/09 14:38

U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite gaining more than 50 points on Friday.

美國股市交投混合,納斯達克綜合指數週五上漲50多點。

The Dow traded down 0.05% to 39,426.08 while the NASDAQ rose 0.36% to 16,720.23. The S&P 500 also rose, gaining, 0.30% to 5,335.46.

道瓊斯指數下跌0.05%至39,426.08,納斯達克上漲0.36%至16,720.23。標準普爾500指數也上漲0.30%至5,335.46。

Leading and Lagging Sectors
Information technology shares climbed by 0.6% on Friday.

領漲與跌幅最大的板塊:
週五,信息技術股上漲了0.6%。

In trading on Friday, industrials shares fell 0.3%.

週五交易中,工業股下跌0.3%。

Top Headline

頭條新聞:

The total number of active U.S. oil rigs increased by three to 485 rigs this week, Baker Hughes Inc reported.

Baker Hughes Inc.報告,本週美國活躍石油鑽機總數增加了3台至485台。

Equities Trading UP

股票上漲:

  • Doximity, Inc. (NYSE:DOCS) shares shot up 36% to $35.02 after the company reported better-than-expected first-quarter financial results. Additionally, the company issued FY24 revenue guidance above estimates.
  • Shares of Iteris, Inc. (NASDAQ:ITI) got a boost, surging 63% to $6.99 after the company announced it will be acquired by Almaviva for $335 million.
  • Blend Labs, Inc. (NYSE:BLND) shares were also up, gaining 19% to $3.2050 after the company reported better-than-expected second-quarter financial results. Also, William Blair upgraded the stock from Market Perform to Outperform.
  • Doximity,Inc. (紐交所:DOCS)股票價格上漲36%至35.02美元,公司公佈了超預期的第一季度財務業績。此外,該公司發行的辦公室物業服務的FY24營收預估高於市場預期。
  • Iteris,Inc. (納斯達克:ITI)股票價格上漲63%至6.99美元,該公司宣佈將被 AlmaViva 收購,交易金額爲3,350萬美元。
  • Blend Labs,Inc. (紐交所:BLND)股價也上漲了19%至3.2050美元,該公司公佈了超預期的第二季度財務業績。此外,William Blair將該公司的股票從市場表現判斷提升到市場外表現。

Equities Trading DOWN

股票下跌:

  • AN2 Therapeutics, Inc. (NASDAQ:ANTX) shares dropped 60% to $1.0650 after the company announced that it will discontinue its EBO-301 study following topline results from its Phase 2 part of the study in treatment-refractory patients with MAC lung disease.
  • Shares of Vicinity Motor Corp. (NASDAQ:VEV) were down 64% to $0.1091. Vicinity Motor will release financial results for the second quarter, after the closing bell on Wednesday, Aug. 14.
  • Meta Materials Inc. (NASDAQ:MMAT) was down, falling 44% to $1.16 after the company disclosed in an SEC filing that it ceased operations and filed a voluntary petition for relief under the provisions of Chapter 7 of Title 11 in the US Bankruptcy Court.
  • AN2 Therapeutics,Inc. (納斯達克:ANTX)股價下跌了60%至1.0650美元,該公司宣佈將根據治療難治性肺MAC病患者的II期研究結果,停止EBO-301研究。
  • Vicinity Motor Corp. (納斯達克:VEV) 股價下跌了64%至0.1091美元。Vicinity Motor將在週三,8月14日的收盤後公佈第二季度財務業績。
  • Meta Materials Inc. (納斯達克:MMAT)股價下跌44%至1.16美元。該公司在提交給美國破產法院第11章第7條款的自願申請中披露,其已停止運營。

Commodities
In commodity news, oil traded up 0.9% to $76.85 while gold traded up 0.2% at $2,467.20.

商品雜項
在商品市場消息方面,石油價格上漲0.9%至76.85美元,黃金價格上漲0.2%至2,467.20美元。

Silver traded down 0.3% to $27.515 on Friday, while copper rose 0.7% to $3.9865.

週五,白銀價格下跌0.3%至27.515美元,而銅價格上漲0.7%至3.9865美元。

Euro zone

歐元區:

European shares closed higher today. The eurozone's STOXX 600 rose 0.57%, Germany's DAX rose 0.24% and France's CAC 40 rose 0.31%. Spain's IBEX 35 Index rose 0.76%, while London's FTSE 100 rose 0.28%.

今日歐洲股市收盤走高。歐元區的STOXX 600指數上漲0.57%,德國的DAX指數上漲0.24%,法國的CAC 40指數上漲0.31%。西班牙的IBEX 35指數上漲0.76%,倫敦的富時100指數上漲0.28%。

Asia Pacific Markets

亞太市場

Asian markets closed mixed on Friday, with Japan's Nikkei 225 gaining 0.56%, Hong Kong's Hang Seng Index gaining 1.17%, China's Shanghai Composite Index falling 0.27% and S&P BSE Sensex gaining 1.04%.

週五,亞洲市場表現不一,日本的日經225指數上漲了0.56%,香港的恒生指數上漲了1.17%,中國的上證綜指下跌了0.27%,印度的S&P BSE Sensex上漲了1.04%。

Economics

經濟學

The total number of active U.S. oil rigs increased by three to 485 rigs this week, Baker Hughes Inc reported.

Baker Hughes Inc.報告,本週美國活躍石油鑽機總數增加了3台至485台。

Now Read This:

現在閱讀這個:

  • Top 3 Utilities Stocks That Could Lead To Your Biggest Gains This Month
  • 這個月最有潛力帶來最大收益的前3家公用事業公司的股票。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論